These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 26757188)
1. Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease. Vijayaraghavan S; Darreh-Shori T; Rongve A; Berge G; Sando SB; White LR; Auestad BH; Witoelar A; Andreassen OA; Ulstein ID; Aarsland D J Alzheimers Dis; 2016; 50(2):567-76. PubMed ID: 26757188 [TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease. Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913 [TBL] [Abstract][Full Text] [Related]
3. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study. Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307 [TBL] [Abstract][Full Text] [Related]
4. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects. De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J; J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841 [TBL] [Abstract][Full Text] [Related]
5. No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases. Maetzler W; Keller S; Michelis J; Koehler N; Stransky E; Becker C; Schulte C; Melms A; Gasser T; Berg D Neurobiol Dis; 2009 Aug; 35(2):296-301. PubMed ID: 19481150 [TBL] [Abstract][Full Text] [Related]
6. BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline. Lane R; He Y; Morris C; Leverenz JB; Emre M; Ballard C Mov Disord; 2009 Feb; 24(3):392-400. PubMed ID: 19006190 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease. Darreh-Shori T; Siawesh M; Mousavi M; Andreasen N; Nordberg A J Alzheimers Dis; 2012; 28(2):443-58. PubMed ID: 22012848 [TBL] [Abstract][Full Text] [Related]
8. Plasma butyrylcholinesterase activity: a possible biomarker for differential diagnosis between Alzheimer's disease and dementia with Lewy bodies? Josviak ND; Batistela MS; Souza RKM; Wegner NR; Bono GF; Sulzbach CD; Simão-Silva DP; Piovezan MR; Souza RLR; Furtado-Alle L Int J Neurosci; 2017 Dec; 127(12):1082-1086. PubMed ID: 28504037 [TBL] [Abstract][Full Text] [Related]
9. Effect of apolipoprotein E and butyrylcholinesterase genotypes on cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer's disease. Patterson CE; Todd SA; Passmore AP Pharmacogenomics J; 2011 Dec; 11(6):444-50. PubMed ID: 20644562 [TBL] [Abstract][Full Text] [Related]
10. Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment. Sokolow S; Li X; Chen L; Taylor KD; Rotter JI; Rissman RA; Aisen PS; Apostolova LG J Alzheimers Dis; 2017; 56(1):229-237. PubMed ID: 27911294 [TBL] [Abstract][Full Text] [Related]
11. Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation. Holmes C; Ballard C; Lehmann D; David Smith A; Beaumont H; Day IN; Nadeem Khan M; Lovestone S; McCulley M; Morris CM; Munoz DG; O'Brien K; Russ C; Del Ser T; Warden D J Neurol Neurosurg Psychiatry; 2005 May; 76(5):640-3. PubMed ID: 15834019 [TBL] [Abstract][Full Text] [Related]
12. No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease. Ki CS; Na DL; Kim JW; Kim HJ; Kim DK; Yoon BK Am J Med Genet; 1999 Apr; 88(2):113-5. PubMed ID: 10206226 [TBL] [Abstract][Full Text] [Related]
13. The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. Ballard C; O'Brien J; Morris CM; Barber R; Swann A; Neill D; McKeith I Int J Geriatr Psychiatry; 2001 May; 16(5):499-503. PubMed ID: 11376466 [TBL] [Abstract][Full Text] [Related]
14. Effect of rivastigmine or memantine add-on therapy is affected by butyrylcholinesterase genotype in patients with probable Alzheimer's disease. Han HJ; Kwon JC; Kim JE; Kim SG; Park JM; Park KW; Park KC; Park KH; Moon SY; Seo SW; Choi SH; Cho SJ Eur Neurol; 2015; 73(1-2):23-8. PubMed ID: 25376930 [TBL] [Abstract][Full Text] [Related]
16. Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease. Jasiecki J; Limon-Sztencel A; Żuk M; Chmara M; Cysewski D; Limon J; Wasąg B Sci Rep; 2019 Mar; 9(1):5223. PubMed ID: 30914707 [TBL] [Abstract][Full Text] [Related]
17. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Lehmann DJ; Johnston C; Smith AD Hum Mol Genet; 1997 Oct; 6(11):1933-6. PubMed ID: 9302273 [TBL] [Abstract][Full Text] [Related]
18. Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease. Raygani AV; Zahrai M; Soltanzadeh A; Doosti M; Javadi E; Pourmotabbed T Neurosci Lett; 2004 Nov; 371(2-3):142-6. PubMed ID: 15519745 [TBL] [Abstract][Full Text] [Related]
19. Butyrylcholinesterase K and apolipoprotein ε4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease. Yoo HB; Lee HW; Shin S; Park SW; Choi JS; Jung HY; Cha J; Lee JM; Lee JY Curr Alzheimer Res; 2014 Feb; 11(2):137-44. PubMed ID: 24479631 [TBL] [Abstract][Full Text] [Related]
20. Failure to confirm a synergistic effect between the K-variant of the butyrylcholinesterase gene and the epsilon4 allele of the apolipoprotein gene in Japanese patients with Alzheimer's disease. Yamamoto Y; Yasuda M; Mori E; Maeda K J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):94-6. PubMed ID: 10369830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]